Regulator Name,Regulator Type,Regulator Subtype,Regulator HGNC Symbol,Regulator Database,Regulator ID,Regulator Compartment,Regulator Compartment ID,Regulated Name,Regulated Type,Regulated Subtype,Regulated HGNC Symbol,Regulated Database,Regulated ID,Regulated Compartment,Regulated Compartment ID,Sign,Connection Type,Mechanism,Site,Cell Line,Cell Type,Tissue Type,Organism,Unnamed: 0,Score,Source,Statements,Paper IDs,Evidence Score,Match Score,Kind Score,Epistemic Value,Total Score
stat3,protein,transcription factor,stat3,uniprot,p40763,nucleus,go:0005634,mtor,protein,kinase,mtor,uniprot,p42345,cytoplasm,go:0005737,negative,d,phosphorylation,,hnscc cells,epithelial-like,head and neck,human,['101'],nan,nan,"possible proteins involved were detected in xenografts and hnscc cells through western blot and immunohistochemistry to further explore the mechanism by which targeting stat3 triggers cell death and autophagy, as well as to elucidate the role of p-stat3t705 in each process. at least 30 autophagy-related genes have been identified [43]. mtor is an autophagy-related gene that negatively modulates autophagosome formation in eukaryotic cells [44]. in the present research, we evaluated the level of phosphorylated mtor to detect whether or not mtor is involved in nsc74859-induced autophagy. nsc74859 treatment decreased the phosphorylation levels of akt and mtor as well as the phosphorylation substrates of mtor (p-s6s235/236) in cal27 cells. this result indicates that the akt/mtor signaling pathway is involved in nsc74859-induced autophagy in cal27 cells. the erk signaling cascade plays a key role in autophagy regulation [45, 46]. however, the mechanism underlying this regulation process has yet to be elucidated. the present results verified the importance of erk activation in nsc74859-induced autophagy. the level of p-erk1/2t202/204 increased in cal 27 cells treated with different concentration of nsc74859 for 24 h. the erk phosphorylation inhibitor u0126 was employed to further confirm the role of erk1/2 in nsc74859-induced autophagy [47]. treatment with 100 μm nsc74859 and 20 μm u0126 for 24 h decreased the levels of lc3ii and p-erk1/2t202/204 in cal27 cells. this result suggests that autophagic flux can be suppressed by inhibiting the phosphorylation of erk1/2.",pmc4791252,1,100,40,1,140
brafv600e,protein,kinase,braf,uniprot,p15056,cytoplasm,go:0005737,erk,protein,kinase,mapk1,uniprot,p28482,cytoplasm,go:0005737,positive,d,triggers,,colon cancer,epithelial,colon,human,['176'],nan,nan,"in conclusion, it is clear from this ex vivo study that autophagy is triggered by brafv600e and the signalling pathway raf/mek/erk. furthermore, the cytoprotective role of autophagy in colon cancer cell lines bearing this mutation is a new and promising target for the future anti- cancer strategy on patients with mutant brafv600e. it is also proposed that autophagy could be targeted in nonbrafv600e colorectal tumors by selected existing or novel autophagy inhibitors.",pmc4891035,1,100,40,1,140
stat3,protein,,stat3,uniprot,p40763,nucleus,go:0005634,jak,protein,kinase,jak,uniprot,o60674,plasma membrane,go:0005886,negative,d,inhibits,,,head and neck squamous cell carcinoma,,human,['100'],nan,nan,"stat3 is an attractive therapeutic target because its development and regulation display an oncogenic phenotype [5, 33]. sen et al. found that the jak kinase inhibitor azd1480 abrogates stat3 activation and head and neck squamous cell carcinoma tumor growth [34]. peyser et al. reported that ptprt is frequently hypermethylated in hnscc and ptprt promoter and methylation is significantly associated with sensitivity to stat3 inhibition in hnscc cells [35]. study by bonner et al. suggested that head and neck cancer cells were more sensitive to cetuximab after the inhibition of stat-3 by an inhibiting short hairpin rna (shrna) knockdown approach [36]. sen et al. [37] generated a double-stranded stat3 oligonucleotide decoy and conducted a clinical trial in head and neck tumors. however, the results of initial clinical trials that utilized stat3 inhibitors are unsatisfactory. blocking p-stat3 potently stimulates the autophagic flux [11]. however, whether or not autophagy promotes cell death or enhances survival remains controversial. drug-induced autophagy of tumor cells has been reported [38, 39], but most studies support the survival role of autophagy in chemotherapy-induced cell death [40, 41]. therefore, the potential cause of treatment failure in these settings may be the pro-survival role of autophagy induced by stat3 inhibitors. considering that the pharmacological or genetic inhibition of autophagy promotes nsc74859-induced apoptosis, we speculated that nsc74859-mediated autophagy is a pro-survival mechanism rather than a pro-death mechanism. these observations are consistent with other reports [42]. a xenograft tumor model was established by the subcutaneous inoculation of cal27 cells into nude mice treated with both nsc74859 and cq. co-treatment reduced tumor volume compared with nsc74859 alone, indicating that blocking the autophagic flux can enhance the efficacy of nsc74859 on hnscc cells.",pmc4791252,1,100,40,1,140
ampk,protein,,prkaa1,uniprot,q13131,cytoplasm,go:0005737,mtor,protein,,mtor,uniprot,p42345,cytoplasm,go:0005737,negative,i,promotes,,,,,,['318'],nan,nan,"pten has a stimulatory effect on autophagy, by downregulating pi3k/akt signaling. it is a critical regulator of the pi3k pathway [39], which selectively hydrolyzes pip3 to pip2, and inhibits the activation of akt/pkb. akt inhibition leads to suppression of mtor signaling and the induction of autophagy [39]. unlike the ras/raf/erk and pi3k pathways, ampk (amp-activated protein kinase) pathway has a negative effect on mtor signaling and promotes autophagy. upon starvation and activation of calcium signaling, ampk phosphorylates and activates tsc2, which inhibits mtor signaling.",pmc4182068,1,100,40,1,140
lc3b,protein,,lc3b,uniprot,q9gzq8,tumours,,mtor,protein,kinase,mtor,uniprot,p42345,cytoplasm,go:0005737,negative,i,inhibition,,bca (mcf-7 and mda-mb-231) cells,breast cancer,breast,human,['375'],nan,nan,"lc3b is highly expressed in tumours as compared with normal tissues. activation of lc3b in na-treated bca (mcf-7 and mda-mb-231) cells was evident as compared with other autophagy makers. further, our results confirmed that na-transcriptionally regulates lc3b (as confirmed by mrna levels and reporter assay), which resulted in the formation of acidic autophagy vesicles and autolysosomes in bca cells. nimocinol acetate inhibited mtor-mediated pro-survival signalling that resulted in inhibition of growth in bca cells without affecting normal breast epithelial cells. downregulation of lc3b expression by sirna significantly inhibited the anticancer effects of na in bca cells.",pmc4102935,1,100,40,1,140
egfr,protein,membrane-spanning tyrosine kinase receptor,egfr,uniprot,p00533,membrane,go:0016020,akt,protein,serine/threonine protein kinase,akt1,uniprot,p31749,cytoplasm,go:0005737,positive,d,activation,downstream,,cancer,,human,['276'],nan,nan,"in cancer cells, radiation-induced or constitutive signaling pathways that act through receptor tyrosine kinases (rtks) are implicated in modulating radioresistance. egfr, an erbb family member, is a membrane-spanning tyrosine kinase receptor that plays an important role in regulating tumor cell proliferation, survival, invasion, and angiogenesis. high-level egfr expression is correlated with radioresistance and poor outcome after radiotherapy in preclinical and clinical studies [185,186]. egfr exerts prosurvival and pro-proliferation activities through the activation of downstream signaling pathways, including the pi3k/akt, stat, and ras–raf–mapk [187,188,189]. among them, the pi3k/akt pathway is a key downstream survival pathway activated in cancer cells. the akt serine/threonine protein kinase, a central kinase downstream of pi3k, is involved in different aspects of cellular regulation, such as cell growth, proliferation, survival, migration/invasion, metastasis, angiogenesis, and metabolism.",pmc4661850,1,100,40,1,140
cd95/fas,protein,pro-apoptotic,fas,uniprot,p25445,plasma membrane,go:0005886,jnk,protein,,mapk8,uniprot,p45983,cytoplasm,go:0005737,positive,d,activation,,,,,human,['109'],nan,nan,"interestingly, increased apoptosis in tumor tissue is observed early in tumorigenesis. a possible reason for this is that rapid reparative epithelial proliferation, possible fusion events with inflammatory macrophages, and selection by lymphoid cells promotes early genetic instability required for tumor transformation and progression. the associated dna damage in turn activates the intrinsic apoptosis pathway. excessive apoptosis can lead to immune dysfunction within the tumor microenvironment. recent studies indicate that loss of pro-apoptotic genes, such as cd95/fas and puma, promotes tumorigenesis by activation of jnk, or sustains tumor stem cell survival.5, 6, 7 these findings raise the possibility that apoptosis promotes early tumorigenesis.8",pmc3877563,1,100,40,1,140
brafv600e,protein,,braf,uniprot,p15056,plasma membrane,go:0005886,mek,protein,,map2k1,uniprot,q02750,cytoplasm,go:0005737,positive,i,feedback re-activation,,,,colorectal,,['134'],nan,nan,"the specific brafv600e inhibitors vemurafenib [27] and dabrafenib accomplish relatively short periods of antitumor activity before the appearance of resistance and treatment failure. a number of different mechanisms that may contribute to tumor resistance to drug therapy have been proposed, including a feedback re-activation of egfr in colorectal cancer [24-26, 28-30]. several studies and clinical trials in various cancer types have long been focusing on combining specific brafv600e inhibitors with other kinase or receptor growth factor inhibitors, like mek, pi3k and egfr [31-33, 44]. towards this end, combined inhibition of autophagy and oncogenic braf may be particularly efficient, as braf-driven tumors induce and require mitochondrial metabolism, and therefore may need autophagy to supply substrates, such as glutamine, to replenish tca cycle intermediates and to eliminate damaged mitochondria [34].",pmc4891035,1,100,40,1,140
pi3k,protein,,pik3ca,uniprot,p42336,,,pten,protein,,pten,uniprot,p60484,,,positive,d,genetic mutations,apoptotic pathway,,,brain,human,['198'],nan,nan,"malignant glioblastomas are the most common form of brain cancer. late stages of brain cancer are associated with poor prognosis and the average survival rate of patients diagnosed with malignant glioma generally does not exceed two years [58,59]. while treatment of glioblastoma includes radiotherapy and chemotherapy, generally, glioblastomas (gbms) are resistant to the current therapeutics due to the hyperactivation of the pi3k-akt-mtor survival pathway by excessive stimulation via growth factor receptors and ras [60]. most gbms carry mutations on the pten gene, whose function is to inhibit the continuous activation of pi3k/akt [60,61]. as the apoptotic pathway is also frequently inactivated due to genetic mutations [58,62], gbms are considered to be relatively resistant to cytotoxic insults [63,64].",pmc4100138,1,10,38,1,48
akt,protein,,akt1,uniprot,p31749,cytoplasm,go:0005737,mtor,protein,,mtor,uniprot,p42345,cytoplasm,go:0005737,negative,d,inhibition,,malignant glioma cells,glial,brain,human,['19'],nan,nan,"curcumin induced g2/m arrest and autophagy in malignant glioma cells through the inhibition of the akt/mtor/p70s6k and activation of the extracellular signal-regulated kinase (erk)1/2 pathways, which implied that cell death via autophagy, might be pathway specific.",pmc4260725,1,10,38,1,48
mtor,protein,,mtor,uniprot,p42345,cell,go:0005623,p70s6k,protein,,rps6kb1,uniprot,p23443,cell,go:0005623,positive,d,phosphorylation,,,,,na-treated bca cell lines,['383'],nan,nan,"bca cell lines were seeded in six-well plates, and after 24 h of culture, the cells were treated with na at different dose and time. western blotting was performed using specific antibodies against, atg3, atg5, atg7, atg12, beclin 1, lc3a, lc3b (autophagy antibody sampler kit #4445, cell signaling), mtor (#2972), pmtor (#2974), p70s6k (#2708), phospho-p70s6k (#9234), bax (#2772), bcl-2 (#2876), cleaved caspase-3 (#9661), cleaved caspase-9 (#9505), parp (#9542) and cleaved parp (#9541) (cell signaling), and β-actin (santa cruz biotechnology, dallas, tx, usa). protein–antibody complexes were detected with the enhanced chemiluminescence method as described earlier (suman et al, 2013b).",pmc4102935,1,1,40,1,41
mtor,protein,kinase,,uniprot,p42345,cytosol,go:0005829,ampk,protein,kinase,prkaa1,uniprot,q13131,cytosol,go:0005829,negative,d,inhibition,,,lung tumor,lung,human,['196'],nan,nan,"autophagic cell death in lung tumor cells. the combination of pemetrexed and sorafenib as well as iron oxide alone can result in the inhibition of mtor, leading to autophagic cell death. alterations in cellular atp levels due to mitochondrial depolarization have been shown to cause activation of ampk, an established initiator of autophagy. activation of p53 up regulates the ulk1/ulk2 pathway; not shown is that this may occur downstream of ampk activation. anacardic acid increases er (endoplasmic reticulum) stress, which can further lead to an increase in beclin-1 levels, a key regulator of autophagy. loss of pten promotes activation of mtor, which leads to inhibition of ulk1/ulk2 and interference with autophagy induction.",pmc4100138,1,1,40,1,41
mammalian target of rapamycin 1,protein,,,uniprot,p42345,,,unc-51-like kinase 1,protein,,ulk1,uniprot,o75385,,,negative,d,dissociates,,,,,mammalian,['112'],nan,nan,"during starvation, mammalian target of rapamycin 1 dissociates from the unc-51-like kinase 1 (ulk1) complex, allowing it to initiate autophagosome formation. there are at least three class iii phosphatidylinositol 3 kinase (pi3kc3)–beclin-1 complexes that are involved in the regulation of autophagosome formation. the atg14l (atg14l–beclin-1–hvps34–p150) and uvrag (uvrag–beclin-1–hvps34–p150) complexes are required for autophagy, whereas the rubicon complex (rubicon–uvrag–beclin-1–hvps34–p150) negatively regulates autophagy. moreover, discovery and identification of beclin-1-binding protein increases the complexity of this process.11 microtubule-associated protein light chain 3 (lc3)-ii as an autophagosome marker ultimately degrades in the autolysosome. impairment of the early and late steps of autophagy can have opposing effects on the number of autophagy-related vacuoles, as well as lc3-ii expression. autophagy is not only a nonselective bulk process in response to starvation but also a highly selective quality control mechanism in regulation of organelle turnover, cellular debris disposal, and pathogen clearance (figure 3b).",pmc3877563,1,1,40,1,41
akt,protein,,akt1,uniprot,p31749,cytoplasm,go:0005737,lc3i/ii,protein,,map1lc3b,uniprot,q9gzq8,cytoplasm,go:0005737,negative,i,inhibition,,cal27,epithelial-like,oral squamous cell carcinoma,human,['90'],nan,nan,"a. cal27 cells were treated with different concentration of nsc74859 for 24 h, the level of akt, p-akts473, mtor, p-mtors2448, s6 and p-s6s236/236 were analyzed by western blot in left part. relative quantitative data were calculated by image j in the right part; b. western blotting of nsc74859-induced autophagy following the overexpression of a constitutively active form of akt (myr-akt). cells were transfected with an akt overexpression (myr-akt) or empty vector (pcdna3) plasmid for 24 hours and then treated with 100 μm of nsc74859 for 24 hours. levels of akt, p-akts473, and lc3i/ii were measured by western blotting. c. cal27 cells were treated with different concentration of nsc74859 for 24 h, the level of erk 1/2 and p-erk 1/2t202/204 were analyzed by western blot in left part; relative quantitative data were calculated by image j in the right part; d. cal27 cells were treated with100 μm of nsc74859 for 6, 12 and 24 h, then western blot was performed to analyze the protein erk 1/2 and p-erk 1/2t202/204; relative quantitative data were calculated by image j in the right part; e. cal27 cells were treated with 100 μm of nsc74859 in the presence or absence of the erk phosphorylation inhibitor u0126 (20 μm) for 24 h. the level of lc3i/ii, erk 1/2 and p-erk 1/2t202/204 were determined by western blot analysis in left part. relative quantitative data were calculated by image j in the right part. *p < 0.05, **p < 0.01 versus the control group, one-way anova with post-dunett analysis was used by graphpad prism5, #p < 0.05 versus the ncs74859 (100 μm) group, one-way anova with post-tukey analysis was used by graphpad prism5.",pmc4791252,1,1,40,1,41
akt,protein,,akt1,uniprot,p31749,,,dna-pkcs,protein,,prkdc,uniprot,p78527,dna dsb site,,positive,d,forms a functional complex,dna dsb site,,,,mammals,['278'],nan,nan,"as mentioned above, two pathways are involved in dna dsb repair: the nhej and hr pathways. in the nhej repair pathway, akt forms a functional complex with dna-pkcs at the dna dsb site and stimulates dna–pkcs kinase activity, all of which are necessary for the dna dsb repair. akt-dependent phosphorylation/activation of dna-pkcs indicates that akt is involved in the first initiating step of dna dsb repair [199]. akt can also be activated by the mre11–rad50–nbs1 (mrn)–atm pathway as well as the pi3k pathway. the role of akt in dsb repair is further substantiated by radiation-induced colocalization of γh2ax foci and phosphorylated akt in the site of dsb [199,200,201]. brca1, brca2, and rad51 are critical components of the hr repair pathway, to which akt activity is also linked. particularly, whereas akt stimulates the nhej pathway, its aberrant activation suppresses the hr pathway and generates genetic instability in tumor cells [202]. because nhej is the predominant pathway in mammals, activation of the egfr/pi3k/akt signaling pathway is crucial for tumor cell survival after radiation and the inhibition of akt activity by targeting the rtk–pi3k–akt axis suppresses faithful repair of ir-induced dna dsbs and improves radiotherapy efficacy [203,204,205,206].",pmc4661850,1,1,40,1,41
beclin-1,protein,,becn1,uniprot,q14457,,,bcl-xl,protein,,bcl2l1,uniprot,q07817,,,negative,d,inhibits,,,,,,['182'],nan,nan,"beclin-1 and atg5 are two genes that have been shown to be required for the promotion of autophagy [16,17], and consequently interfering with beclin-1 and/or atg5 expression should reduce autophagy and protect against autophagic cell death. two independent pathways that can theoretically induce autophagic cell death include canonical and non-canonical autophagy [15,16,17,18]. in the canonical autophagy pathway, beclin-1 is essential for the initiation of autophagy through its interaction with the class iii phosphatidylinositol-3-kinase vps34 [18]. interaction of beclin-1 with the anti-apoptotic bcl-2-family proteins bcl-2 and bcl-xl inhibits beclin-1 function while the expression of beclin-1 mutants that are unable to associate with bcl-2 leads to a high level of autophagy and cell death.",pmc4100138,1,0.1,39,1,39.1
bcl-xl,protein,antiapoptotic,bcl2l1,uniprot,q07817,endoplasmic reticulum,go:0005783,beclin-1,protein,,becn1,uniprot,q14457,endoplasmic reticulum,go:0005783,negative,d,binds,bh3 domain,,,,,['29'],nan,nan,"on the other hand, the antiapoptotic bcl-2 family members from the endoplasmic reticulum and not the mitochondria, such as bcl-2 and bcl-xl, inhibit autophagy by binding to the bh3 domain of beclin-1.23 furthermore, recent data suggest that the oncogenic effect of bcl-2 arises from its ability to inhibit autophagy but not apoptosis. inhibition of bcl-2 leads to autophagic cell death in mcf7 breast cancer cells.24 therefore these evidences suggest that modulating autophagy may be important in designing anticancer therapies.22 finally, studies suggest that the genetic makeup of cells will determine its fate in terms of undergoing autophagy and response to standard or novel therapies.",pmc4260725,1,0.1,39,1,39.1
hmgb1,protein,,hmgb1,uniprot,p09429,,,retinoblastoma,protein,tumor suppressor,rb1,uniprot,p06400,nucleus,go:0005634,negative,d,binding,,,,breast cancer,,['120'],nan,nan,"hmgb1 dysfunction is associated with each of the hallmarks of cancer.32 serum hmgb1 and hmgb1 expression in cancer tissue are generally increased in the setting of cancer. hmgb1 release promotes tumor growth, proliferation, and metastasis owing to its cytokine, chemokine, and growth factor activity. however, hmgb1 also functions as a breast cancer suppressor by binding to retinoblastoma, a tumor suppressor protein.33 a dynamic relationship between intracellular and extracellular pools of hmgb1 in tumorigenesis remains to be fully investigated.",pmc3877563,1,0.1,39,1,39.1
hmgb1,protein,,hmgb1,uniprot,p09429,,,tlr2,protein,,tlr2,uniprot,o60603,,,negative,d,neutralizing,,,,,human,['300'],nan,nan,"we used the subsequent cell lines: bgc-823 (low differentiated stomach adenocarcinoma cell line), sgc-7901 (moderately differentiated stomach adenocarcinoma cell line) and gastric epithelial cells (ges-1) (immortalized fetal gastric mucosal cell line), mkn28 (well-differentiated adenocarcinoma cell line) and mkn45 (poorly differentiated adenocarcinoma cell line). these cell lines were kindly provided by dr yujuan dong (department of surgery, the chinese university of hong kong, shatin, hong kong, china). the cell lines were routinely cultured in rpmi-1640 medium supplemented with 10% fetal bovine serum (fbs) (both from gibco, carlsbad, ca, usa) and maintained at 37°c in a humidified environment with 5% co2. gefitinib was obtained from cayman chemical (ann arbor, mi, usa) and glycyrrhizic acid, mtt, human recombinant hmgb1, rabbit-derived anti-human hmgb1 antibodies were obtained from sigma. neutralizing anti-rage, anti-tlr2 and anti-tlr4 and isotype-matched control (igg) were from r&d systems (minneapolis, mn, usa), and the gfp-lc3 expression vector was kindly provided by professor george g. chen (department of surgery, the chinese university of hong kong, shatin, hong kong, china).",pmc4358082,1,0.1,39,1,39.1
hmgb1,protein,,,uniprot,p09429,cytoplasm,go:0005737,rage,protein,,ager,uniprot,q15109,cell membrane,go:0005886,positive,d,binds,,,epithelial,gastric carcinoma,human,['310'],nan,nan,"in conclusion, the present study demonstrated (fig. 7) that hmgb1 was highly expressed, particularly within the cytoplasm of human gastric carcinoma cells. as a regulator of cell death and survival, hmgb1 was released from the tumor cells undergoing gefitinib-induced autophagy, bound with rage and initiated signaling involving phosphorylation of erk1/2, which contributed to gastric tumor cell proliferation. thus, we propose hmgb1 release as a pro-survival signal for residual cells following various cytotoxic cancer treatments. hmgb1 inhibitors or rage suppressants may be effective in prohibiting cancer regrowth, supported by hmgb1-related autophagy during chemotherapy. such methods may be considered for future chemotherapy protocols to increase their efficacy in human gastric adenocarcinoma and other epithelial neoplasms.",pmc4358082,1,0.1,39,1,39.1
hmgb1,protein,,,uniprot,p09429,extracellular,go:0005576,rage,protein,,ager,uniprot,q15109,plasma membrane,go:0005886,positive,d,interacts,extracellular,,gastric tumor,,human,['305'],nan,nan,"several receptors have been linked to hmgb1 signaling, including rages and tlrs (14,15). we analyzed tlr2, tlr4 and rage gene expression in human gastric tumor cells using quantitative real-time pcr. the three receptors were expressed in multiple gastric tumor cell lines in vitro. interestingly, rage expression was greater in the bgc-823 cells, where hmgb1 was relatively highly expressed (data not shown). to assess the contribution of rage to erk activation and tumor growth, sirna was designed to silence rage. rage expression was significantly reduced in the sirage group as long as 96 h post-transfection, which covered the maximal duration of the cell proliferation assay (fig. 6a). rage knockdown almost completely abrogated erk phosphorylation in response to hmgb1 (fig. 6b). to confirm the interaction of extracellular hmgb1 and its receptor, anti-tlr2, anti-tlr4 and anti-rage antibodies were used to block the respective receptors in bgc-823 cells. consistent with the rage knockdown results, anti-rage antibodies significantly lowered the erk response to hmgb1, although anti-tlr2 and anti-tlr4 antibodies demonstrated no inhibition of erk response (fig. 6b). thus, hmgb1-induced erk activation is dependent on rage. cells subjected to different treatments were analyzed via mtt assay to investigate the rage involvement in hmgb1-induced cell proliferation. compared to the sirna-control, the rage-reduced bgc-823 cells displayed markedly decreased proliferation in response to recombinant hmgb1 or mixed medium (a mixture of gefitinib-treated cell medium and fresh medium in a ratio of 7:3) (fig. 6c and d). extracellular hmgb1 interacted with rage and activated erk signaling responsible for gastric cancer cell proliferation.",pmc4358082,1,0.1,39,1,39.1
lamp2b,protein,,lamp2,uniprot,p13473,lysosome,go:0005764,lc3-ii,protein,,map1lc3b,uniprot,q9gzq8,cytosol,go:0005829,positive,d,cleavage,,colon cancer cells,epithelial-like,colon,human,['66'],nan,nan,"trincheri et al.112 reported that autophagy can be induced with acute exposure to resveratrol, whereas prolonged exposure activated a caspase-mediated cell death pathway. they observed that genetic inactivation of pi3k, beclin-1, and lamp2b inhibited resveratrol toxicity. beclin-dependent autophagy was confirmed when supplementing the cells with asparagine or knocking down beclin-1 by rna interference, abrogated the effect. the effect of lamp2b was confirmed when its silencing inhibited the fusion of autophagosomes with lysosomes and induced cell viability. interestingly, zvad-fmk inhibited cell death but not autophagy. this study uncovered a novel pathway of resveratrol cytotoxicity in which autophagy has two roles, that is, a prosurvival stress response that later in the process, changes to a caspase-dependent apoptotic response. in another study, resveratrol increased ros level with induction of caspase-8 and caspase-3 cleavage and elevation of lc3-ii expression in colon cancer cells; these effects were diminished by nac.113",pmc4260725,1,0.1,39,1,39.1
lc3,protein,,map1lc3a,uniprot,q9gzq8,cytoplasm,go:0005737,p62 (sqstm1),protein,,sqstm1,uniprot,q13501,cytoplasm,go:0005737,positive,d,binds,,,colon adenocarcinoma,colon,human,['136'],nan,nan,"different colon adenocarcinoma cell lines were examined with respect to autophagic properties. in all cell lines, presence of autophagy was tested through the relative levels of lc3ii using western blot (figure 1a, lanes 1-6) and then confirmed with mdc staining- a molecule that stains autophagic vacuoles. phalloidin was used for cytoskeleton staining, in order to assess the number of cells present in each sample (figure 1b(i)). a strong association between lc3ii and p62 (sqstm1) expression and mdc positive staining of autophagic vacuoles in colon cancer cell lines was revealed. in detail, protein levels of the autophagic marker lc3 (i and ii) were found elevated in dld-1 (lane 1), hct116 (lane 2) and rko (lane 4) cells, while lower was the expression in sw620 (lane 3) and colo-205 (lane 5) adenocarcinoma cell lines. furthermore, lc3 staining revealed also high protein distribution in dld-1 (figure 1b(ii)). the ratio between lc3ii and lc3i protein levels was notably higher in dld-1 and ht29 as compared to the other cell lines. the levels of becn1 were found elevated only in hct116 and sw620 cell lines, whereas the ratio between lc3ii/lc3i was low. the flux of autophagy was also examined through western blot analysis of p62 protein levels, which were found elevated in dld-1 and colo-205 and reduced in sw620 and ht29 cells, as compared to the other cell lines (figure 1a). alongside, mrna level analysis, showed higher than 3-fold mrna lc3 expression in dld-1, colo-205, sw620 and rko, as compared to caco-2 intermediate colon adenoma cells. the mrna levels of becn1 were found increased by at least 2-fold in dld-1, sw620, colo-205 and ht29 as compared to caco-2 (figure 1c). notably, rko, hct116 and sw620 cell lines exhibit properties of epithelial-mesenchymal-transition (emt) phenotype. these results propose a putative relation between autophagy and the emt cell programs.",pmc4891035,1,0.1,39,1,39.1
lc3,protein,,map1lc3a,uniprot,q9gzq8,,,p62,protein,,sqstm1,uniprot,q13501,,,positive,d,binds,,,,,,['130'],nan,nan,"becn1, rarely mutated in tumors [20], and lc3 proteins are two key components of the autophagic process. precisely, lc3-bi is converted to lc3-bii through lipidation by an ubiquitin-like system involving atg7 and atg3 that allows lc3 to become associated with autophagic vesicles. p62 (sqstm1) is thought to be another critical protein that targets other proteins for proteasome degradation or autophagic digestion, at the crossroads of autophagy, apoptosis and cancer. in particular, lc3-ii binds p62 to regulate protein packaging and delivery to the autophagosome [3]. both the presence of lc3 in autophagosomes and the conversion of lc3 to the lower migrating form, lc3-ii, have been used as indicators of autophagy [3, 7]. mammalian becn1, also known as autophagy-related gene (atg6), has been shown to interact with bcl-2 and bcl2l1 [8]. furthermore, becn1 and its binding partner pik3c3, also known as vps34, are required for the initiation of the autophagosome formation. on the other hand, the mtor signaling pathway downstream of akt, is a critical regulator of autophagy. activation of mtor can inhibit the autophagic process [9].",pmc4891035,1,0.1,39,1,39.1
lc3b,protein,microtubule-associated protein,,uniprot,q9gzq8,autophagosome membrane,go:0005776,lc3-i,protein,cytosolic form of lc3,,uniprot,q9h492,cytosol,go:0005829,positive,d,conversion,lipidation,bca cell lines,breast cancer,breast,human,['391'],nan,nan,"we next evaluated an important autophagy marker, lc3b, a microtubule-associated protein, which has an critical role in autophagy, especially in the formation of the autophagosome (mizushima and yoshimori, 2007). during autophagy induction, lc3-i, a cytosolic form of lc3, is converted to lc3-ii by lipidation, which facilitates its binding with the membranes of autophagosomes (kabeya et al, 2000). treatment with na upregulated lc3a (a-i and a-ii) and lc3b (b-i and b-ii) expression in a dose- and time-dependent manner in bca cell lines (figures 3b and d). however, a significant induction of lc3b was seen as compared with lc3a in both bca cell lines. further, na activates lc3b promoter in mcf-7 (5.4-fold) and mda-mb-231 (4.2-fold) cells (figure 3e). in addition, we also confirmed a transcriptional regulation of lc3b in both cell lines (supplementary figure 5).",pmc4102935,1,0.1,39,1,39.1
bcl-2,protein,negative regulator of autophagy,bcl2,uniprot,p10415,cytoplasm,go:0005737,beclin-1,protein,,becn1,uniprot,q14457,cytoplasm,go:0005737,negative,d,interaction,,h460/cis,nsclc,lung,human,['197'],nan,nan,"another commonly used chemotherapeutic drug to treat lung cancer is cisplatin. however, its use is limited due to acquired resistance from prolonged treatment. studies conducted by sirichanchuen et al. [56] showed a reduction in autophagy to be the underlying mechanism for this acquired resistance. using two h460 cells lines, one sensitive to cisplatin (h460) and one rendered resistant to cisplatin by exposure to gradually increasing concentrations of drug (h460/cis), these investigators established that a reduction in autophagy levels led to a decrease in cisplatin-mediated cell death, supporting a cytotoxic function of autophagy. furthermore, resistance could be reversed, making h460/cis cells more sensitive to treatment, by inducing autophagy using tfp (trifluoperazine). conversely, the chemosensitizing effects of tfp could be reversed using the autophagy inhibitor, 3-ma. mechanistically, long-term cisplatin treatment has been shown to cause over expression of bcl-2, which as indicated above, acts as a negative regulator of autophagy via its interaction with beclin-1 [57]. consistently in this study bcl-2 was shown to be higher in the h460/cis cell line implicating its role in reduced autophagy in cisplatin-resistant cells (h460-cis) compared to parental nsclc cells (h460).",pmc4100138,1,0.1,39,1,39.1
hmgb1,protein,,hmgb1,uniprot,p09429,intracellular,go:0005622,beclin-1,protein,,becn1,uniprot,q14457,intracellular,go:0005622,positive,d,regulates,,,malignant tumors,,human,['308'],nan,nan,"autophagy is a cell survival mechanism in many types of malignant tumors (25,26). kang et al (27) found that intracellular hmgb1 regulates autophagy through interaction with beclin-1, in competition with bcl-2, indicating its functional importance in cross-regulating apoptosis and survival. however, detailed functions of extracellular hmgb1 remain largely undefined. our data showed that exogenous hmgb1 induced a dose-dependent upregulation of bgc-823 cell proliferation (fig. 4a and b). treatment with a medium containing hmgb1 released from the autophagic cells resulted in enhanced cell growth. therefore, hmgb1 released by autophagic cells serves as a pro-survival signal for residual cells.",pmc4358082,1,0.1,39,1,39.1
bcl-2,protein,,bcl2,uniprot,p10415,mitochondria,go:0005739,beclin 1,protein,,becn1,uniprot,q14457,plasma membrane,go:0005886,negative,d,binds,,,cancer,,human,['379'],nan,nan,"autophagy is considered to be a second type of programmed cell death (lum et al, 2005). the molecular signalling for both autophagy and apoptosis are interconnected, as both share and target mitochondrial degradation that results in inhibition of several pro-survival signalling molecules, including bcl-2 and bclxl. these pro-survival genes bind to beclin 1, and form a trimeric complex, which inhibits beclin 1-mediated autophagy function, resulting in proliferation and survival of cancer cells (furuya et al, 2005; pattingre et al, 2005).",pmc4102935,1,0.1,39,1,39.1
bcl-2,protein,,bcl2,uniprot,p10415,mitochondria,go:0005739,bax,protein,,bax,uniprot,q07812,mitochondria,go:0005739,positive,i,upregulated,,na-treated bca cell lines,,,human,['396'],nan,nan,"as bcl-2 and bclxl in complex with beclin1 have been shown to inhibit autophagy in many cancer cells, we subsequently analysed bcl-2 expression in na-treated cells. as expected, downregulation of bcl-2 expressions occurred in na-treated bca cell lines (figure 5b). these findings prompted us to evaluate the expression levels of bax, a pro-apoptotic protein. the ratio of bcl-2 and bax levels determines whether cells survive or undergo apoptosis, with a high bcl-2/bax ratio favouring survival and a low bcl-2/bax ratio favouring apoptosis. nimocinol acetate-treatment led to upregulated bax expression in both bca cell lines in a time-dependent manner (figure 5b). we also found that the cleaved forms of caspase-9, caspase-3, and poly (adenosine diphosphate-ribose) polymerase (parp), proteins involved in apoptosis were increased in na-treated cells. however, activation of pro-apoptotic proteins did not lead to induction of apoptosis. these observations suggest that autophagy governs the downstream pro-apoptotic effectors to execute growth arrest in bca cells.",pmc4102935,1,0.1,39,1,39.1
p53,protein,,tp53,uniprot,p04637,nucleus,go:0005634,cyclin b1,protein,,ccnb1,uniprot,p14635,cytoplasm,go:0005737,positive,d,increased expression,,,,,,['248'],nan,nan,"interestingly, mitotic catastrophe can be enhanced by p53 deficiency and a weakened g2/m checkpoint [48,49]. the induction of mitotic catastrophe induced by ir is associated with the increased expression of cyclin b1 and the kinase activity of cdc2 [50]. g2/m checkpoint disruptors, such as caffeine, okadaic acid, or staurosporine, have been shown to promote ir-induced mitotic catastrophe [51]. mitotic cell death is also enhanced by inactivating mutations in g2/m checkpoint genes, such as p21 and 14-3-3-σ [49,52]. these findings suggest that ir-induced cellular damage may induce the premature entry of cells into mitosis and that mitotic cell death may be a key contributor to the loss of clonogenic potential in tumor cells and solid tumors exposed to ir, especially those with p53 deficiency.",pmc4661850,1,0.1,39,1,39.1
p53,protein,tumor suppressor gene,tp53,uniprot,p04637,nucleus,go:0005634,ulk2,protein,autophagy inducing gene,ulk2,uniprot,q8iyt8,cytoplasm,go:0005737,positive,d,activation,,,,,,['195'],nan,nan,"the tumor suppressor gene, p53, which is uniformly activated in response to dna damage by radiation, can induce autophagy through the activation of autophagy inducing genes, particularly ulk1 and ulk2. this activation of ulk1 and ulk2 lead to an elevation in autophagy levels in response to dna damage and contributes to cell death [54]. a possible mechanism by which activated mtor inhibits cytotoxic autophagy is by preventing ulk1 activation [55]. thus, loss of pten followed by an increase in mtor activity could lead to an increase in clonogenic survival. therefore, the studies by kim et al. [53] suggest that inhibiting mtor signaling could be an effective strategy to increase radiosensitivity.",pmc4100138,1,0.1,39,1,39.1
pkcδ,protein,,prkcd,uniprot,q05655,cytoplasm,go:0005737,tg2,protein,,tgm2,uniprot,p21980,cytoplasm,go:0005737,positive,i,induction,,pancreatic cancer,epithelial-like,pancreas,human,['44'],nan,nan,"the first evidence of massive autophagy induction leading to death only in cells with pkcδ via induction of tg2 was reported in pancreatic cancer cells.12, 13 however, recent studies suggested that rottlerin can also induce apoptosis through pkcδ-independent mechanisms in fibrosarcoma cells.75 it was suggested that the early autophagy might serve as a survival mechanism against late apoptosis in this cancer type.76",pmc4260725,1,0.1,39,1,39.1
rage,protein,,ager,uniprot,q15109,extracellular space,go:0005615,hmgb1,protein,,hmgb1,uniprot,p09429,extracellular space,go:0005615,positive,d,activation,mapk,,gastric cancer,stomach,human,['304'],nan,nan,rage is required for hmgb1-induced mapk activation and gastric cancer cell proliferation,pmc4358082,1,0.1,39,1,39.1
stat3,protein,,stat3,uniprot,p40763,nucleus,go:0005634,caspase 3,protein,,casp3,uniprot,p42574,cytoplasm,go:0005737,negative,i,inhibition,,cal27 and fadu hnscc cell lines,epithelial,head and neck,human,['80'],nan,nan,"we investigated the effects of blocking stat3 phosphorylation by nsc74859 (s3i-201) on apoptosis in hnscc cell lines cal27 and fadu. cultured cal27 cells were treated with nsc74859 at increasing concentration. hoechst nuclear staining was used to test cell apoptosis in nsc74859-treated hnscc cal27 cells; figure 1a shows a positive staining of chromatin condensation. treatment with nsc74859 increased tunel-positive cells in a dose-dependent manner (supplementary figure s1a). cal27 cells were also analyzed by flow cytometry after annexin v-fitc and pi dual labeling. as shown in figure 1b, cells were treated with different concentration of nsc74859 for 24 h or 100 μm nsc74859 for 6, 12, and 24 h (figures 1b and 1c). this treatment increased the percentage of apoptotic cells. western blot analysis showed that the level of cleaved parp (cl-parp) and cleaved-caspase 3 (cl-casp3) increased with decreasing p-stat3t705 expression; this effect was dose and time dependent (figures 1d and 1e). to further demonstrate whether nsc74859-induced apoptosis in cal27 cells was correlated to the activation of caspase3, a pan-caspase inhibitor benzyloxycarbonyl val-ala-asp (o-methyl)-fluoro-methylketone (z-vad-fmk) was employed. the results showed that when nsc74859 was combined with the treatment of 20 μm of z-vad-fmk, the level of cleaved-parp (supplementary figure s1b) and the apoptotic cells (supplementary figure s1c) were significantly decreased. these results reveal that nsc74859-induced apoptosis in cal27 cells may partially depend on caspase 3 activation. the in vitro inhibition experiment was repeated in another cell line fadu (supplementary figure s2). these results indicate that apoptosis is involved in the response of hnscc to nsc74859 treatment.",pmc4791252,1,0.1,39,1,39.1
beclin1,protein,,becn1,uniprot,q14457,cytoplasm,go:0005737,atg3,protein,,atg3,uniprot,q6uxz4,cytosol,go:0005829,positive,d,induction,,"mcf-7, mda-mb-231",breast cancer,breast,human,['400'],nan,nan,"in our results, no significant inductions of beclin1 expression were observed in na-treated bca cells. beclin 1 is thought to be an important autophagy-regulated factor and beclin 1 activation is thought to be essential for induction of autophagy in bca cells. however, a recent study found that beclin 1 is non-functional in some bca cells because of a mutation in one of the beclin 1 alleles (liang et al, 1999; qu et al, 2003). thus, we studied other key regulators of autophagy, the atgs, that initiate autophagosome and autolysosome formation, which eventually lead to cellular breakdown and recycling (reviewed in eskelinen and saftig, 2009). nimocinol acetate induced atg3 protein expression, as compared to atg7 or atg12 expression, in a dose- and time-dependent manner. we also saw a moderate induction of atg5 in na-treated mcf-7 and mda-mb-231 cells. activation of atg3, atg5, and atg12 initiates the pre-autophagosome and promotes the conversion of lc3b-i to lc3b-ii, which facilitates the formation of the double membrane of the autophagosome (reviewed in tanida et al, 2004). the conversion of lc3b-i to lc3b-ii is an indicator of autophagosome formation, and the results of the confocal microscopy analysis suggested that lc3b was localised in vacuoles (puncta) in na-treated cells. the formation of an increased number of autophagy vacuoles in na-treated bca cells suggests a breakdown of cytosolic cellular components within the lysosome. in addition, kinetic analyses of autophagosome and autolysosome formation in mcf-7, mda-mb-231, and mcf-12a cells were performed, with or without na treatment, by live cell imaging. initiation of autophagosome formation, followed by autolysosome formation, was prominent in bca cells treated with na; however, induction of autophagosome/autolysosome formation was less pronounced in normal breast epithelial cells treated with na. formation of autophagosomes is an early event in autophagy. the fusion of autophagosomes with lysosomes (i.e., formation of autolysosomes) is a critical step in initiation of cell death (trincheri et al, 2008). the degradation of the lysosome has been suggested to be the determining event in induction of autophagy- and necrosis-mediated cell death (kroemer and jaattela, 2005).",pmc4102935,1,0.1,39,1,39.1
hmgb1,protein,,hmgb1,uniprot,p09429,,,atg7,protein,,,uniprot,q9h0y0,,,positive,i,regulation,,bgc-823,gastric cancer,,human,['301'],nan,nan,"hmgb1 is released from tumor cells undergoing classical necrotic cell death. recent discoveries suggest that autophagy regulates selective hmgb1 release in tumor cells (8,16). in the present study, we observed that gefitinib, an epidermal growth factor receptor (egfr) inhibitor, activated autophagy in the gastric cancer cells, as indicated by lc3-positive puncta and increased the levels of the autophagosome-bound form of lc3, lc3 ii (fig. 3a and b). gefitinib-induced autophagy triggered a dose-dependent increase in hmgb1 release into the media of the bgc-823 cells. western blot analysis showed that hmgb1 protein was reduced in the bgc-823 cells and increased in the supernatants, after treatment with gefitinib (fig. 3b). knockdown of atg7 or beclin-1 prevented hmgb1 release from the gefitinib-treated cells suggesting regulation by autophagy (fig. 3c). at 12 h post-gefitinib treatment, cytoplasmic hmgb1 levels declined, however, nuclear hmgb1 expression showed no significant change by 24 h after treatment (fig. 3d). furthermore, we utilized elisa to quantify the hmgb1 released in culture supernatants. consistent with the western blot analysis results, the hmgb1 released from the gefitinib-treated cells was significantly increased in a time-and dose-dependent manner compared with that released in the untreated cells (fig. 3e). this demonstrated that hmgb1, particularly the cytoplasmic hmgb1, was rapidly released and accumulated in the culture media of the gefitinib-treated gastric tumor cells.",pmc4358082,1,0.1,39,1,39.1
hmgb1,protein,,hmgb1,uniprot,p09429,extracellular,go:0005576,mcl-1,protein,,,uniprot,q07820,mitochondria,go:0005739,positive,i,upregulation,,bgc-823,,gastric carcinoma,human,['306'],nan,nan,"hmgb1 is actively secreted from activated innate immune cells or passively from cells undergoing classical necrotic cell death (4). recently, it was observed that hmgb1 was selectively released from tumor cells undergoing autophagy (8,16). evidence suggests that hmgb1 may induce autophagy in cancers associated with increased sensitivity to cytotoxic anticancer agents (10). contrarily, hmgb1-mediated autophagy may protect gastric cancer cells from the chemotherapeutic vinca alkaloid, vincristine (23). in the present study, data indicated that the protective effects of hmgb1 occurred through its upregulation of the protein myeloid cell leukemia-1 (mcl-1). other studies suggest that vincristine may reduce mcl-1 expression and promote the death of cancer cells (24), complicating the interpretation of our findings. autophagy, a process in which subcellular membranes undergo dynamic morphological changes resulting in intracellular degradation of proteins, cytoplasmic organelles and pathogens, is a mechanism exploited by tumor cells for survival and used in determining tumor response to anticancer therapy. increasing evidence suggests that autophagy represents a resistant mechanism to chemotherapy in many malignancies and our findings support this notion. here we observed that bgc-823 cells (an egfr-rich human gastric carcinoma cell line) were resistant to the egfr tyrosine kinase inhibitor, gefitinib. the ic50 value of gefitinib for growth inhibition of bgc-823 cells was 92.83±1.92 μm (data not shown).",pmc4358082,1,0.1,39,1,39.1
caspase-3,protein,,casp3,uniprot,p42574,cytoplasm,go:0005737,beclin-1,protein,,becn1,uniprot,q14457,cytoplasm,go:0005737,positive,d,cleavage,,,,,,['37'],nan,nan,"studies have shown that there is a complex interplay between the apoptotic and autophagic processes. autophagy may precede apoptosis or be induced simultaneously depending on the genetic context and cellular background of the cells. oligomerized caspase-8 binds autophagosome membrane, leading to its activation and creating a mechanism for transition from apoptosis to autophagy.53 experimental findings suggest that activated caspase-3 can cleave beclin-1, producing a fragment that translocates to mitochondria and induces apoptosis.54",pmc4260725,1,0.1,39,1,39.1
becn1,protein,,becn1,uniprot,q14457,cytoplasm,go:0005737,hif-1α,protein,,hif1a,uniprot,q16665,nucleus,go:0005634,negative,d,inhibition,,nude mice,tumor,subcutaneous,mouse,['351'],nan,nan,"a. the subcutaneous tumors were established in nude mice by implanting sgc-shcontrol and sgc-shbecn1 cells. tumor masses of all mice were measured twice a week and tumor volume was calculated. b. the expression of becn1, hif-1α, e-cadherin and glut1 in xenografts from sgc-shcontrol, sgc-shbecn1 and sgc-shbecn1 + nac groups were determined by immunohistochemical analysis. scale bar, 100 μm. c. liver metastatic mice models were induced by splenic inoculation of sgc-shcontrol and sgc-shbecn1 cells. the liver metastatic mice of three groups were counted respectively. the white arrows pointed to metastatic nodules in livers. bars represent mean ± sd. *: p < 0.05.",pmc4741864,1,0.1,39,1,39.1
becn1,protein,,becn1,uniprot,q14457,cytoplasm,go:0005737,lc3,protein,,map1lc3,uniprot,q9gzq8,cytoplasm,go:0005737,positive,i,overexpression,,ht29 and sw620,epithelial,colon adenocarcinoma,human,['137'],nan,nan,"therefore, the protein levels of autophagic markers becn1 and lc3 are overexpressed in selected colon adenocarcinoma cell lines. ht29 and sw620 cell lines show induced autophagic properties as revealed by high mdc staining and low p62 protein levels.",pmc4891035,1,0.1,39,1,39.1
becn1,protein,,becn1,uniprot,q14457,,,glut1,protein,,slc2a1,uniprot,p11166,,,positive,d,expression,,,,,,['355'],nan,nan,"first row, the expression of hif-1α, e-cadherin and glut1 in positive becn1 expression case (case 77). second row, the expression of hif-1α, e-cadherin and glut1 in negative becn1 expression case (case 28). scale bar, 100 μm.",pmc4741864,1,0.1,39,1,39.1
becn1,protein,,becn1,uniprot,q14457,,,lc3,protein,,map1lc3a,uniprot,q9h492,,,positive,d,overexpression,,,colon,adenocarcinoma,human,['143'],nan,nan,becn1 and lc3 are overexpressed in brafv600e colorectal adenocarcinomas real-time analysis of human colorectal cancer samples for becn1 and lc3 mrna,pmc4891035,1,0.1,39,1,39.1
becn1,protein,,,uniprot,q14457,,,e-cadherin,protein,,cdh1,uniprot,p12830,,,negative,i,correlation,,,,gastric cancer,human,['353'],nan,nan,"in this study, tissue microarrays (tmas) consisting of human gastric cancer tissues from 156 patients were used to research the correlation between autophagy and clinical features of gastric cancer. according to becn1 expression in these tissues, 156 cases were divided into high expression group (58, 37.2%) and low expression group (98, 62.8%). consistent with previous study [12], negative expression of becn1 was positively associated with poorer histology differentiation (p = 0.020, table 1) and more advanced clinical stage (p < 0.001, table 1). compared with patients in the group with high expression of becn1, patients in the low expression group were more likely to accompany with deeper tumor invasion (p = 0.074, table 1) and lymph node metastasis (p = 0.061, table 1), although these differences were not statistically significant. moreover, becn1 expression was negatively correlated with expression of hif-1α (p = 0.042) and glut-1 (p = 0.046), and positively correlated with e-cadherin expression (p = 0.006) in gastric cancer tissues (table 1; figure 8 & supplementary figure s5). there was no significant correlation between becn1 expression and age or gender of gastric cancer patients.",pmc4741864,1,0.1,39,1,39.1
beclin-1,protein,,becn1,uniprot,q14457,,,bcl-2,protein,,bcl2,uniprot,p10415,,,negative,d,binding,beclin-1,mcf-7,cancer,breast,human,['67'],nan,nan,"an interesting non-canonical autophagic process characterized by a beclin-1/vps34-independent pathway was observed in mcf-7 cancer cells in response to resveratrol treatment. overexpression of bcl-2, which is known to block canonical starvation-induced autophagy by binding to beclin-1, was unable to reverse the non-canonical autophagy triggered by resveratrol in these breast cancer cells.8, 114",pmc4260725,1,0.1,39,1,39.1
beclin-1,protein,,becn1,uniprot,q14457,cytoplasm,go:0005737,p62/sqstm1,protein,,sqstm1,uniprot,q13501,cytoplasm,go:0005737,positive,d,increase in protein levels,,,colon cancer,colon,human,['25'],nan,nan,"the induction of cellular senescence was accompanied by autophagy in colon cancer cells with an increase in beclin-1 and p62/sqstm1 protein levels. therefore, the functional link between senescence and autophagy in these curcumin-treated cancer cells should be further investigated.",pmc4260725,1,0.1,39,1,39.1
hmgb1,protein,,hmgb1,uniprot,p09429,cytoplasm,go:0005737,rage,protein,,ager,uniprot,q15109,plasma membrane,go:0005886,positive,i,activation,extracellular,,gastric cancer,stomach,human,['296'],nan,nan,autophagy-mediated hmgb1 release promotes gastric cancer cell survival via rage activation of extracellular signal-regulated kinases 1/2,pmc4358082,1,0.1,39,1,39.1
calreticulin,protein,,calr,uniprot,p27797,endoplasmic reticulum,go:0005783,purinergic p2x7 receptor,protein,,p2rx7,uniprot,q99572,plasma membrane,go:0005886,positive,d,interact,,,dcs,,human,['118'],nan,nan,"more recently, increasing evidence suggests that particular damps serve as powerful immunological adjuvants and mediate icd in cancer therapy.17, 18 icd is the process by which damps from dying cells contribute to immune-mediated eradication of tumors during chemotherapy (for example, anthracyclines), radiotherapy, or pdt (for example, hypericin-based photodynamic therapy, hyp-pdt) (figure 4). icd is characterized by the exposure to and/or release of calreticulin,19 hmgb1,20 hsp70/hsp90,21, 22 and atp23 from pro-apoptotic, post-apoptotic, and/or necrotic cells. calreticulin, hmgb1/hsps, and atp then interact with the receptors cd91, toll-like receptor 4(tlr4), and purinergic p2x7 receptors, respectively, which are present on the surface of dcs. cd91, tlr4, and p2x7 are present on dcs and promote engulfment of dying cells, presentation of tumor antigens, and production of inflammasome-dependent il-1β release, respectively. a tumor-specific immune response, such as the cytotoxic t lymphocyte or nk response, is triggered to kill (and cull) cancer cells during cancer therapy. apart from these damps and signaling, a recent study suggested that accumulation of cation-independent mannose-6-phosphate receptor on the tumor cell surface is also important for icd.24 of note, the signaling pathways elicited by distinct icd inducers (for example, anthracyclines and hyp-pdt) overlap but are not identical. interestingly, icd-mediated tumor clearance following chemotherapy works only in tumor cell line transplantation models or the immunogenic 3-methylcholanthrene fibrosarcoma model but not in spontaneous tumor models.25 therefore, it appears that icd is dependent on additional factors such as tumor type and convergent signals in the tumor microenvironment. below, we highlight examples of damps as immunogenic effectors to icd and their multiple functions in cancer.",pmc3877563,1,0.1,39,1,39.1
beclin-1,protein,,becn1,uniprot,q14457,cytoplasm,go:0005737,bcl-2,protein,,bcl2,uniprot,p10415,mitochondrion,go:0005739,negative,d,binds,,,breast tumor,,,['188'],nan,nan,"autophagic cell death in breast tumor cells. in the canonical pathway, beclin-1 is essential for the initiation of autophagy. bcl-2 binds to beclin-1 and interferes with its capacity to promote autophagy; conversely, silencing of bcl-2 can lead to autophagic cell death. autophagy induced in the non-canonical pathway is independent of beclin-1 function. resveratrol is one agent that induces non-canonical autophagic cell death in breast tumor cells. endoplasmic reticulum (er) stress mediates autophagy by inhibiting the akt/mtor/4ebp1 signaling pathway and can induce both apoptosis and autophagic cell death. autophagic cell death can serve as a backup mechanism in cells where apoptosis is inhibited, by agents such as the caspase inhibitor, z-vad-fmk. intraconversion between cytoprotective autophagy and autophagic cell death can be observed in mcf-7 and zr-75-1 breast tumor cells when radiation treatment is combined with vitamin d or a vitamin d analog.",pmc4100138,1,0.1,39,1,39.1
beclin-1,protein,,becn1,uniprot,q14457,cytoplasm,go:0005737,bcl-2,protein,,bcl2,uniprot,p10415,mitochondria,go:0005739,negative,i,silencing,,mcf-7 breast tumor cells,epithelial-like,breast,human,['183'],nan,nan,"studies conducted by akar et al. [17] have shown that when beclin-1 function is left unchecked by silencing of bcl-2, excessive levels of autophagy induce cell death in mcf-7 breast tumor cells exposed to doxorubicin. in these studies, autophagy was monitored based on increased levels of acridine orange staining, expression of lc3-ii (a protein associated with the membrane of the autophagosome) and beclin-1 expression while the absence of apoptosis induction was based on low or insignificant levels of annexin v staining and parp (poly(adp-ribose)polymerase) cleavage. furthermore, silencing of atg5 inhibited doxorubicin induced autophagic cell death in bcl-2 silenced cells. this is interesting from the standpoint that silencing of the anti-apoptotic protein, bcl-2, might otherwise be expected to be permissive for apoptosis.",pmc4100138,1,0.1,39,1,39.1
egfr,protein,tyrosine kinase,egfr,uniprot,p00533,cell membrane,go:0005886,beclin-1,protein,autophagy initiating protein,becn1,uniprot,q14457,cytoplasm,go:0005737,negative,d,phosphorylation,multiple sites,,cancerous,various,human,['2'],nan,nan,"macroautophagy (hereafter, autophagy) is evolutionally well-conserved in eukaryotes as the major degradation mechanism whereby cellular proteins and organelle are sequestered into a double-membrane vesicle (autophagosome) and are delivered to lysosomes. they are then membrane-fused (autolysosome) and cargos are degraded for metabolic recycling by lysosomal hydrolytic enzymes, including protease (7,8). it has become apparent that many aggressive cancer cells have upregulated autophagy and are dependent on autophagy for survival (9). egfr tyrosine kinase (egfr-tk) is overexpressed or somatic mutationally activated in a broad range of human cancers, including nsclc and pancreatic cancers (10). activated egfr suppresses autophagy via activation of mammalian targets of rapamycin (mtors), as well as tyrosine phosphorylation of beclin-1 (11–13). in response to ligand binding, egfr becomes a dimer and is activated via tyrosine phosphorylation. phosphorylated egfr subsequently activates intracellular pro-survival and anti-apoptotic signals. one of the downstream activated egfr signals involves the pi3k/akt/mtor pathway, made up of well-established negative regulators for autophagy (14). in response to nutrient and growth factor availability, mtor promotes cell growth while suppressing autophagy. in addition, the activated egfr binds the autophagy initiating protein beclin-1, leading to multisite tyrosine phosphorylation and enhanced binding to autophagy inhibitors, including rubicon (15). thus, exposure to egfr-tkis such as gefitinib (gef) and erlotinib (erl) induces autophagy via cancellation of the pi3k/akt/mtor pathway, as well as blocking phosphorylation of beclin-1, which subsequently leads to dissociation of rubicon from beclin-1 to initiating autophagy (13,15). a recent report confirmed that inactivated endosomal, but not cell surface egfr interacts with laptm4b, resulting in a complex formation for recruiting rubicon from beclin-1 (16). as described above, dissociation of rubicon from beclin-1 is essential for autophagy initiation. cancer cells with higher egfr expression could thus be supported and survive by efficient autophagy induction under various metabolic stresses, such as low nutrient and hypoxic conditions due to insufficient vascularization (15,16). therefore, if autophagy induction in response to egfr-tki promotes tumor cell survival, combined treatment with an autophagy inhibitor may promote tumor cell death.",pmc4734605,1,0.1,39,1,39.1
egfr,receptor,,egfr,uniprot,p00533,plasma membrane,go:0005886,vegf,protein,,vegfa,uniprot,p15692,extracellular space,go:0005615,positive,d,upregulation,,,cancer,,human,['275'],nan,nan,"the interactions among hypoxia, angiogenesis, and radioresistance are well known. activation of the pi3k/akt pathway, an important pathway involved in radioresistance, contributes to the increased transcription and expression of hif-1 [182]. vegf, a major transcription target of hif-1 in hypoxic conditions, regulates various endothelial cell functions and induces tumor neovascularization [183,184]. one of the important mechanisms by which inhibition of the epidermal growth factor receptor (egfr) enhances tumor oxygenation is the regulation of vegf. cooperation between the pten mutation and egfr activation upregulates vegf even under normoxic conditions through the pi3k/akt pathway. tumor cell proliferation and angiogenesis, which may be implicated in radioresistance, require the interaction between egfr and vegf and downstream signaling of the pi3k/akt pathway.",pmc4661850,1,0.1,39,1,39.1
beclin 1,protein,,becn1,uniprot,q14457,,,bcl-2,protein,,bcl2,uniprot,q07817,,,negative,d,binds,,,,,,['362'],nan,nan,"deficiencies in autophagy lead to the accumulation of damaged macromolecules and organelles (particularly mitochondria), subsequently inducing oxidative stress, dna damage and chromatin instability (levin and klionsky, 2004; chen and karantza, 2011). thus, autophagic defects are ultimately associated with the accumulation of oncogenic mutations and increased tumor susceptibility (karanta-wadsworth et al., 2007; mathew et al., 2007). some of the most important evidence for the role of autophagy in tumor suppression comes from studies on the bcl-2-interacting protein, beclin 1 (becn1, also called atg6). for example, monoallelic deletion of beclin 1 has been frequently observed in human breast (futreal et al., 1992), ovarian (aita et al., 1999) and prostate cancers (gao et al., 1995), and mice with a disrupted beclin 1 gene had a higher incidence of lymphoma, lung cancer and liver cancer (qu et al., 2003; yue et al., 2003). constitutive activation of the pi3k-akt-mtor axis, a common characteristic of cancer (lopiccolo et al., 2008), is known to suppress autophagy (janku et al., 2011), while promoting tumor cell growth, proliferation and survival (martelli et al., 2007) (figure 1). a number of tumor suppressor proteins have been shown to promote autophagy, including atg4c (mariño et al., 2007), baxinteracting factor-1 (bif-1) (takahashi et al., 2007), bh3-only proteins (maiuri et al., 2007), dapkinase (bialik and kimchi, 2010), lkb1 (liang et al., 2007), ultraviolet radiation resistance-associated gene (uvrag) (liang et al., 2006), pten (arico et al., 2001), tsc (zhou et al., 2009), nuclear p53 (maiuri et al., 2010) and ampk (luo et al., 2010). furthermore, autophagy has been shown to reduce intratumoral necrosis and local inflammation (degenhardt et al., 2006). collectively, these results support the contention that autophagy plays a tumor-suppressing role in cancer, and suggest that reduced autophagic activity may constitute a hallmark of cancer (hanahan and weinberg, 2011).",pmc3296807,1,0.1,39,1,39.1
hif-1α,protein,,hif1a,uniprot,q16665,nucleus,go:0005634,glut-1,protein,,slc2a1,uniprot,p11166,plasma membrane,go:0005886,positive,i,influence,,,gastric cancer,stomach,human,['346'],nan,nan,"because hif-1α is a key regulator of cell metabolism [21], we tested whether autophagy inhibition could influence cell’ metabolism. as shown in figure 4a and 4b, autophagy defect enhanced total expression of glucose transporter 1 (glut-1) and promoted membrane translocation of glut-1 in gastric cancer cells, the enhanced glut-1 expression could be reverted by 2-meoe2 or nac. correspondingly, the glucose uptake level of sgc-shbecn1 and mgc-shbecn1 cells was increased significantly compared with control cells (figure 4c), meanwhile, the lactate secretion level of these cells was also increased (figure 4d), implying that autophagy defect induces aerobic glycolysis in gastric cancer cells. on the other hand, the concentrations of citrate and fumarate, two intermediates in the tca cycle (tricarboxylic acid cycle) used to form atp, were decreased in sgc-shbecn1 and mgc-shbecn1 cells (figure 4e & 4f), indicating that autophagy defect reduces mitochondrial oxidative phosphorylation level in gastric cancer cells. however, there was no significant difference of atp production between autophagy deficient cells and control cells (figure 4g & 4h). to investigate whether atp generation could be affected by autophagy defect induced glycolysis, all cells were treated with 5 mm 2-dg (2-deoxy-d-glucose, an inhibitor of glycolysis) for 12 h. our results displayed that atp generation of all cells was inhibited by 2-dg and the inhibitory effect was more significant in sgc-shbecn1 and mgc-shbecn1 cells than control cells (figure 4g & 4h), indicating that autophagy deficient cells are more relied on glycolysis to provide energy and the decreased atp production in mitochondria is compensated by increased glycolysis in autophagy deficient cells. besides, the emt couldn't be reverted by 2-dg in sgc-shbecn1 and mgc-shbecn1 cells (supplementary figure s4), demonstrating that autophagy inhibition induced glycolysis has no appreciable effect on emt. altogether, these results suggested that autophagy defect causes the shift from oxidative phosphorylation to glycolysis in gastric cancer cells for maintaining proper energy homeostasis.",pmc4741864,1,0.1,39,1,39.1
hmgb1,protein,,hmgb1,uniprot,p09429,cytoplasm,go:0005737,beclin-1,protein,,becn1,uniprot,q14457,cytoplasm,go:0005737,negative,d,binds,,,tumor,gastric cancer,,['298'],nan,nan,"autophagy is a lysosome-mediated, self-degradation process that protects normal cells, but also promotes tumor cell survival under stress (11). evidence suggests that endogenous hmgb1 is a critical regulator of autophagy in tumor cells. cytoplasmic hmgb1 can directly bind to autophagy protein beclin-1, disrupting beclin-1/bcl-2 interaction and sustaining autophagy (12). endogenous knockdown of hmgb1 with sirna or inhibition of its release with small-molecule inhibitors, abolished the protective effect of autophagy and increased tumor cell sensitivity to several clinically useful agents (10,13). although autophagy may regulate selective hmgb1 release in some tumor types, the mechanisms of its extracellular release from gastric cancer cells undergoing autophagy and activation of surface receptor-mediated intracellular signaling pathways are not well characterized.",pmc4358082,1,0.1,39,1,39.1
hmgb1,protein,,hmgb1,uniprot,p09429,cytoplasm,go:0005737,rage,protein,,ager,uniprot,q15109,plasma membrane,go:0005886,positive,d,interaction,,,gastric cancer cells,gastric carcinoma,human,['299'],nan,nan,"multiple receptor types have been implicated in hmgb1 signaling, including the receptor for advanced glycation end products (rage) and members of the toll-like family of receptors (tlrs) (14,15). in the present study, we showed that hmgb1 was highly expressed in human gastric carcinoma and primarily located in the cytoplasm of gastric cancer cells. gefitinib, a common chemotherapeutic agent, activated autophagy and promoted the release of hmgb1, which was required to maintain gastric tumor cell survival. intriguingly, the interaction between hmgb1 and rage initiated signaling involving erk1/2 phosphorylation and contributed to the cell proliferation in gastric tumor cells.",pmc4358082,1,0.1,39,1,39.1
fasl,protein,,faslg,uniprot,p48023,cell membrane,go:0005886,tnf-α,protein,,tnf,uniprot,p01375,cell membrane,go:0005886,positive,i,death-inducing signaling,,,cancer cell,breast cancer,human,['247'],nan,nan,"mitotic catastrophe or mitotic cell death occurs during aberrant mitosis as a result of aberrant chromosome segregation, leading to formation of giant cells with an aberrant spindle, de-condensed chromatin, and multiple micronuclei. this type of cell death is accompanied by the presence of one or more micronuclei and centrosome overduplication. together with apoptosis, mitotic catastrophe accounts for the majority of ir-induced cancer cell death. mitotic catastrophe occurs due to faulty mitosis and causes delayed mitotic-linked cell death that takes place via apoptosis or necrosis. for example, irradiated breast cancer cells die by apoptosis due to delayed cell death associated with mitotic catastrophe after growth arrest [46]. the fasl, trail (tnf-related apoptosis-inducing ligand), and tnf-α death-inducing signaling pathways mediate mitotic catastrophe in these cancer cells through interactions of their ligands and receptors [47]. in this regard, mitotic catastrophe seems to be an absolute requirement for late-type cell death and accounts for the late apoptosis observed after ir exposure.",pmc4661850,1,0.1,39,1,39.1
pi3k,protein,,pik3ca,uniprot,p42336,cytoplasm,go:0005737,mtor,protein,,mtor,uniprot,p42345,cytoplasm,go:0005737,negative,i,regulation,,,,,,['200'],nan,nan,"the function of autophagy is not always clear. for instance, studies have shown that inhibition of pi3k and mtor has a cytostatic, but not a cytotoxic effect, both in vitro and in vivo [67]. because autophagy is negatively regulated by the pi3k-akt-mtor pathway, interference with this pathway promotes autophagy. while pharmacologic and genetic inhibition of autophagy along with inhibition of pi3k-akt-mtor pathway resulted in apoptosis, this does not necessarily mean that autophagy was functionally cytoprotective since the cells were actually arrested, presumably through the promotion of autophagy [9].",pmc4100138,1,10,19,1,29
akt,protein,,akt1,uniprot,p31749,cytoplasm,go:0005737,mtor,protein,,mtor,uniprot,p42345,cytoplasm,go:0005737,positive,i,involved in,,hnscc cells,squamous cell,head and neck,human,['89'],nan,nan,the akt/mtor and erk signaling pathway are involved in nsc74859-induced autophagy in hnscc cells,pmc4791252,1,10,5,1,15
